Evidence map›Paper›PMID 21593744›Full record

ArticleJournal of human genetics2011

Investigation of modifier genes within copy number variations in Rett syndrome.

Rosangela Artuso, Filomena T Papa, Elisa Grillo, Mafalda Mucciolo, Dag H Yasui, Keith W Dunaway, Vittoria Disciglio, Maria A Mencarelli, Marzia Pollazzon, Michele Zappella and 5 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of human genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Treating Rett syndrome: from mouse models to human therapies.Mammalian genome : official journal of the International Mammalian Genome Society · 2019
    Review
  14. Genetic Causes and Modifiers of Autism Spectrum Disorder.Frontiers in cellular neuroscience · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Rosangela ArtusoBiotechnology Department, Medical Genetics Section, University of Siena, Siena, Italy.
Filomena T Papa
Elisa Grillo
Mafalda Mucciolo
Dag H Yasui
Keith W Dunaway
Vittoria Disciglio
Maria A Mencarelli
Marzia Pollazzon
Michele Zappella
Giuseppe Hayek
Francesca Mari
Alessandra Renieri
Janine M Lasalle
Francesca Ariani
University of Siena · ITUniversity of California, Davis · USOspedale Versilia · IT

Funding

The Role of MeCP2 in Rett SyndromeR01HD041462 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI LASALLE, JANINE M · 2002 to 2011
$2.8M
NICHD NIH HHS R01 HD041462NICHD NIH HHS R01HD041462Telethon GTB07001
6 · The paper itself

Abstract

MECP2 mutations are responsible for two different phenotypes in females, classical Rett syndrome and the milder Zappella variant (Z-RTT). We investigated whether copy number variants (CNVs) may modulate the phenotype by comparison of array-CGH data from two discordant pairs of sisters and four additional discordant pairs of unrelated girls matched by mutation type. We also searched for potential MeCP2 targets within CNVs by chromatin immunopreceipitation microarray (ChIP-chip) analysis. We did not identify one major common gene/region, suggesting that modifiers may be complex and variable between cases. However, we detected CNVs correlating with disease severity that contain candidate modifiers. CROCC (1p36.13) is a potential MeCP2 target, in which a duplication in a Z-RTT and a deletion in a classic patient were observed. CROCC encodes a structural component of ciliary motility that is required for correct brain development. CFHR1 and CFHR3, on 1q31.3, may be involved in the regulation of complement during synapse elimination, and were found to be deleted in a Z-RTT but duplicated in two classic patients. The duplication of 10q11.22, present in two Z-RTT patients, includes GPRIN2, a regulator of neurite outgrowth and PPYR1, involved in energy homeostasis. Functional analyses are necessary to confirm candidates and to define targets for future therapies.

Indexed as

DNA Copy Number VariationsBlood ProteinsChromatin ImmunoprecipitationChromosomes, Human, Pair 1Complement C3b Inactivator ProteinsCytoskeletal ProteinsFemaleHumansMethyl-CpG-Binding Protein 2PhenotypeRett SyndromeBlood ProteinsCFHR1 protein, humanCFHR3 protein, humanComplement C3b Inactivator ProteinsCROCC protein, humanCytoskeletal ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2

Identifiers

PMID21593744
PMCPMC3145144
OpenAlexW1990466151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.